Product
Lutetium Lu 177 dotatate
Aliases
Lutathera
2 clinical trials
4 indications
Indication
Neuroendocrine TumorsIndication
Neuroendocrine Tumor Grade 1Indication
Neuroendocrine TumorIndication
Merkel Cell CarcinomaClinical trial
177Lu-DOTATATE Modified Delivery Based on Individualized DosimetryStatus: Not yet recruiting, Estimated PCD: 2029-01-31
Clinical trial
A Single Arm Study With Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination With Immunotherapy for Patients With Merkel Cell Cancer (HCRN MCC20-443; iPRRT Study)Status: Recruiting, Estimated PCD: 2026-09-01